Rued, Britta E.
Dhariwal, Achal
Covington, Brett C.
Seyedsayamdost, Mohammad R.
Krivograd, Sophie A.
Pesavento, Russell P.
Federle, Michael J.
Petersen, Fernanda C.
Funding for this research was provided by:
National Institutes of Health (K99DE032311)
National Institutes of Health (R00DE032311)
National Institutes of Health (R01-AI162679)
Norges Forskningsråd (322375)
Article History
Received: 21 April 2025
Accepted: 22 July 2025
First Online: 4 August 2025
Competing interests
: The authors report that Tryglysin A has been registered as an Antibacterial Agent under U.S. patent US-20240051995-A1, with M.R.S., M.J.F., B.C.C., and B.E.R. as inventors. The authors have no other competing interests to report.